Cargando…

Off label use of lithium in the treatment of Huntington's disease: A case series

Huntington's disease is characterized by choreic movements, psychiatric disorders, striatal atrophy with selective small neuronal loss, and autosomal dominant inheritance. The genetic abnormality is CAG expansion in Huntingtin gene. Newer therapeutic strategies are evolving to treat this progre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Danivas, Vijay, Moily, Nagaraj S., Thimmaiah, Rohini, Muralidharan, Kesavan, Purushotham, Meera, Muthane, Uday, Jain, Sanjeev
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2013
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3574462/ https://www.ncbi.nlm.nih.gov/pubmed/23439971 http://dx.doi.org/10.4103/0019-5545.105522

Ejemplares similares

Predictive genetic testing in Huntington's disease
por: Muthane, Uday
Publicado: (2011)

Dysplastic cortical formation in a patient with schizophrenia
por: Thimmaiah, Rohini, et al.
Publicado: (2012)

Trinucleotide Repeats and Haplotypes at the Huntingtin Locus in an Indian Sample Overlaps with European Haplogroup A
por: Moily, Nagaraj S, et al.
Publicado: (2014)

A systematic examination of brain volumetric abnormalities in recent-onset schizophrenia using voxel-based, surface-based and region-of-interest-based morphometric analyses
por: John, John P., et al.
Publicado: (2015)

Bifrontal ECT for drug-induced psychosis in Parkinson's disease
por: Muralidharan, K., et al.
Publicado: (2011)

Treatment of Long-Haul COVID Patients With Off-Label Acyclovir
por: German, Emily R, et al.
Publicado: (2023)

Protective Effect of Antioxidants on Neuronal Dysfunction and Plasticity in Huntington's Disease
por: Velusamy, Thirunavukkarasu, et al.
Publicado: (2017)

Psychiatric morbidity and poor follow-up underlie suboptimal functional and survival outcomes in Huntington’s disease
por: Ratna, Nikhil, et al.
Publicado: (2020)

The Spectrum of Movement Disorders in Tertiary Care Centers in India: A Tale of Three Cities
por: Prashanth, LK, et al.
Publicado: (2021)

Current perspectives on chlorpromazine equivalents: Comparing apples and oranges!
por: Danivas, Vijay, et al.
Publicado: (2013)

Aripiprazole in the treatment of Huntington’s disease: a case series
por: Ciammola, Andrea, et al.
Publicado: (2009)

Patterns and predictors of off-label prescription of psychiatric drugs
por: Vijay, Aishwarya, et al.
Publicado: (2018)

Huntington's Disease: An Immune Perspective
por: Nayak, Annapurna, et al.
Publicado: (2011)

When is off-label off-road?
por: de Vries, E G E, et al.
Publicado: (2019)

When is off-label off-road?
por: de Vries, E G E, et al.
Publicado: (2019)

Off-Label Use of Thrombopoietin Receptor Agonists: Case Series and Review of the Literature
por: Capecchi, Marco, et al.
Publicado: (2021)

A comparative study of access to inpatient psychiatric treatment in a public mental health service in Melbourne during COVID-19
por: Itrat, Annie, et al.
Publicado: (2020)

Gender Differences in the 5 Years Course of Bipolar Disorder after a First Manic Episode: A Retrospective Review
por: Sreedhar, Divyasree, et al.
Publicado: (2017)

Comments on a comparative study of access to inpatient psychiatric treatment in a public mental health service in Melbourne during COVID-19
por: Itrat, Annie, et al.
Publicado: (2021)

Off-label, off-limits? Parental awareness and attitudes towards off-label use in paediatrics
por: Lenk, Christian, et al.
Publicado: (2009)

An adaptive particle swarm optimization-based hybrid long short-term memory model for stock price time series forecasting
por: Kumar, Gourav, et al.
Publicado: (2022)

Biological and Clinical Changes in a Pediatric Series Treated with Off-Label JAK Inhibitors
por: Pin, Alessia, et al.
Publicado: (2020)

Off-Label Use vs Off-Label Marketing of Drugs: Part 1: Off-Label Use—Patient Harms and Prescriber Responsibilities
por: Van Norman, Gail A.
Publicado: (2023)

An open-label study to assess the feasibility and tolerability of rilmenidine for the treatment of Huntington’s disease
por: Underwood, Benjamin R., et al.
Publicado: (2017)

Cognitive Dysfunction in Patients with Renal Failure Requiring Hemodialysis
por: Thimmaiah, Rohini, et al.
Publicado: (2012)

Attitudes toward people with mental illness among medical students
por: Poreddi, Vijayalakshmi, et al.
Publicado: (2015)

Off-Label 9-Valent Human Papillomavirus Vaccination for Actinic Keratosis: A Case Series
por: Wenande, Emily, et al.
Publicado: (2021)

Overdose and off-label psychotropic prescribing in patients with borderline personality disorder: A retrospective series
por: Ning, Anna Y, et al.
Publicado: (2023)

Off-label drugs for obesity
por: Morgan, Andy, et al.
Publicado: (2022)

Tetrabenazine as anti-chorea therapy in Huntington Disease: an open-label continuation study. Huntington Study Group/TETRA-HD Investigators
por: Frank, Samuel
Publicado: (2009)

Subtype-Specific Off-Label Treatment of Rosacea
por: Wienholtz, Nita, et al.
Publicado: (2021)

The Safety of Deutetrabenazine for Chorea in Huntington Disease: An Open-Label Extension Study
por: Frank, Samuel, et al.
Publicado: (2022)

Management of a patient with Huntington’s disease under spinal anaesthesia
por: Juwarkar, Sanjeev Janardan, et al.
Publicado: (2010)

Human rights violations among economically disadvantaged women with mental illness: An Indian perspective
por: Poreddi, Vijayalakshmi, et al.
Publicado: (2015)

Off-label intravitreal brolucizumab for recalcitrant diabetic macular edema: A real-world case series
por: Chakraborty, Debdulal, et al.
Publicado: (2021)

Immature Brain Cortical Neurons Have Low Transcriptional Competence to Activate Antiviral Defences and Control RNA Virus Infections
por: Narayanan, Divya, et al.
Publicado: (2022)

Multiple drugs: Various toxicities, off-label use and no response to off-label therapy: case report
Publicado: (2021)

Lithium response in bipolar disorder correlates with improved cell viability of patient derived cell lines
por: Paul, Pradip, et al.
Publicado: (2020)

Therapeutic Advances for Huntington’s Disease
por: Kumar, Ashok, et al.
Publicado: (2020)

Thalamic Shape Abnormalities in Antipsychotic Naïve Schizophrenia
por: Danivas, Vijay, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_09pbegh57dmtne92c2eh6tc8ae